Drug Type Small molecule drug |
Synonyms A2A-I-01 |
Target |
Mechanism TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization ![]() |
Active Organization- |
Inactive Organization ![]() |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | A2a Pharmaceuticals, Inc.Startup | 05 Dec 2021 |